- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 57
- Founded in 2014
- HQ inSan Diego, California
- http://www.kuraoncology.com
Tuesday, April 28, 2020
-=Kura Oncology (KURA) :
Rises to its highest levels since December on above 9x average volume, posting gains alongside its peer in the cancer treatments development space, Syndax Pharmaceuticals (SNDX); co's pipeline includes a menin-MLL inhibitor, KO-539.
Bitcoin mining chip producer Ebang files for $100 million IPO
Bitcoin miner to public firm
Ebang states IPO returns will majorly serve towards product diversification, company expansion, and collateral for credit facilities with investment banks. No dividend payouts shall be offered to investors, at least shortly. Apart from its blockchain business, the firm has created a telecommunications division which accounts for a paltry 3 percent of annual revenue.
As per documents, the firm recorded revenues of $100 million in 2019, a 63 percent drop from the reported $319 million in 2018. The firm lost $30 million in 2019, compared to a profit of $24 million in 2018. Based on these financials, it’s difficult to foresee a post-IPO increase in share prices.
Ebang leads Bitcoin miner production ahead of rivals Bitmain and Canaan, as per a Frost and Sullivan report quoted on the filing. The firm sells ten miners varied by computing specifics, with the cheapest priced at $300 and the priciest — promising a 44 TH/s output – at $1930.
The miner noted Chinese businesses dominate the mining space. A massive 96 percent of annual revenue and 94 percent of computing power is supplied by Chinese or China-registered companies.
The filing is Ebang’s second attempt at an IPO. In June 2018, the firm looked to raise a mammoth $1 billion as per a draft submitted to the Hong Kong Exchange. However, the filing never materialized and remains in limbo to this day.
Monday, April 27, 2020
Subscribe to:
Posts (Atom)